English

Performance of GPT-5 in Brain Tumor MRI Reasoning

Computer Vision and Pattern Recognition 2025-08-15 v1 Artificial Intelligence

Abstract

Accurate differentiation of brain tumor types on magnetic resonance imaging (MRI) is critical for guiding treatment planning in neuro-oncology. Recent advances in large language models (LLMs) have enabled visual question answering (VQA) approaches that integrate image interpretation with natural language reasoning. In this study, we evaluated GPT-4o, GPT-5-nano, GPT-5-mini, and GPT-5 on a curated brain tumor VQA benchmark derived from 3 Brain Tumor Segmentation (BraTS) datasets - glioblastoma (GLI), meningioma (MEN), and brain metastases (MET). Each case included multi-sequence MRI triplanar mosaics and structured clinical features transformed into standardized VQA items. Models were assessed in a zero-shot chain-of-thought setting for accuracy on both visual and reasoning tasks. Results showed that GPT-5-mini achieved the highest macro-average accuracy (44.19%), followed by GPT-5 (43.71%), GPT-4o (41.49%), and GPT-5-nano (35.85%). Performance varied by tumor subtype, with no single model dominating across all cohorts. These findings suggest that GPT-5 family models can achieve moderate accuracy in structured neuro-oncological VQA tasks, but not at a level acceptable for clinical use.

Keywords

Cite

@article{arxiv.2508.10865,
  title  = {Performance of GPT-5 in Brain Tumor MRI Reasoning},
  author = {Mojtaba Safari and Shansong Wang and Mingzhe Hu and Zach Eidex and Qiang Li and Xiaofeng Yang},
  journal= {arXiv preprint arXiv:2508.10865},
  year   = {2025}
}